72716-87-1

Usage

Uses

Used in Pharmaceutical Synthesis:
2-Methoxypyridine-4-carboxaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
2-METHOXYPYRIDINE-4-CARBOXALDEHYDE is also utilized in the production of agrochemicals, serving as a building block for the creation of effective and targeted pesticides and other agricultural chemicals.
Used in Fine Chemicals and Organic Compounds Production:
2-Methoxypyridine-4-carboxaldehyde is used as a versatile building block in the synthesis of a wide range of fine chemicals and organic compounds, contributing to the diversity of chemical products available for various applications.
Used in Material Development:
2-METHOXYPYRIDINE-4-CARBOXALDEHYDE has potential applications in the development of new materials, where its unique properties can be leveraged to create innovative and improved materials for various industries.
Used in Academic Research:
2-Methoxypyridine-4-carboxaldehyde is utilized in academic research to explore its chemical properties, reactivity, and potential applications in various fields, contributing to the advancement of scientific knowledge.
It is important to handle 2-methoxypyridine-4-carboxaldehyde with caution due to its potential hazardous properties, and it should be used in a controlled laboratory environment to ensure safety.

InChI:InChI=1/C7H7NO2/c1-10-7-4-6(5-9)2-3-8-7/h2-5H,1H3

Upstream product

• 72716-86-0 4-cyano-2-methoxypyridine 
• 123148-66-3 2-methoxy-4-(hydroxymethyl)-pyridine 
• 26156-51-4 methyl 2-methoxyisonicotinate 
• 100848-70-2 2-methoxy-4-methyl-pyridine 
• 105596-63-2 2-methoxy-isonicotinic acid 
• 6313-54-8 2-chloroisonicotinic acid, 
• 563-41-7 semicarbazide hydrochloride 
• 33252-30-1 2-chloro-4-pyridinenitrile 

Downstream Products

• 1060816-39-8 4-ethynyl-2-methoxy-pyridine 
• 123148-73-2 5-[(2-Methoxy-pyridin-4-yl)-(2-vinyl-phenylamino)-methyl]-oxazole-4-carboxylic acid methyl ester 
• 123148-75-4 N-[(4-Hydroxymethyl-oxazol-5-yl)-(2-methoxy-pyridin-4-yl)-methyl]-N-(2-vinyl-phenyl)-formamide 
• 123148-74-3 {5-[(2-Methoxy-pyridin-4-yl)-(2-vinyl-phenylamino)-methyl]-oxazol-4-yl}-methanol 
• 123148-72-1 (2-Methoxy-pyridin-4-yl)-(2-vinyl-phenylamino)-selenoacetic acid Se-methyl ester 
• 123148-71-0 (2-Methoxy-pyridin-4-yl)-(2-vinyl-phenylamino)-acetic acid methyl ester 

Relevant academic research and scientific papers

Transition-Metal-Free Oxidation of Benzylic C-H Bonds of Six-Membered N-Heteroaromatic Compounds

A novel oxidation of benzylic C-H bonds for the synthesis of diverse six-membered N-heteroaromatic aldehydes and ketones has been developed. The obvious advantages of this approach are the simple operation, mild reaction conditions, and without use of toxic reagent and transition metal. The present method should provide a useful access for the synthesis and modification of N-heterocycles.

NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF

There is provided a morpholine derivative represented by General Formula [1A] or a salt thereof. (In the formula, a ring A represents a ring represented by General Formula [I]; * represents a bonding position; Z2 represents CH or the like; Z1 represents CR6 or the like; R6 represents a hydrogen atom or the like; X1 represents CHR7 or the like; R7 represents a hydrogen atom or the like; X2 represents CH2 or the like; R1 and R2 are the same as or different from each other, and each of R1 and R2 represents a hydrogen atom or the like; R3, R4, and R5 are the same as or different from each other, and each of R3, R4, and R5 represents a hydrogen atom, NRaRb, or the like; and each of Ra and Rb represents a hydrogen atom, a C1-8 alkyl group which may have a substituent, or the like.)

COMPOUND OF CAMPTOTHECIN AND PREPARATION AND USE THEREOF

The present disclosure relates to a compound of formula I, a pharmaceutical composition thereof and the use thereof as an anti-tumor drug.

COMPOUND OF CAMPTOTHECIN AND PREPARATION AND USE THEREOF

The present disclosure relates to a compound of formula I, a pharmaceutical composition thereof and the use thereof as an anti-tumor drug.

AROMATIC RING COMPOUND

Provided is an aromatic ring compound having a GPR40 agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity, and is useful as an agent for the prophylaxis or treatment of diabetes and the like.

TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK and F 93574) and related compounds

The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described.Side-chains associated with H2 antagonist activity are attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring.Good H2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H2-receptor.High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models ledto compound 16c, 2--5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK and F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.H2-receptor antagonists / 2-amino-4-pyrimidones (isocytosines / imidazoles / thiazoles / pyridines / furans / 2-guanidinothiazoles / donetidine (SK and F 93574)

5-(HYDROXYPYRIDYLALKYL)-4-PYRIMIDONES

The compounds are substituted 2-amino-4-pyrimidones with a 5-(hydroxypyridylalkyl) substituent which are histamine H 2-antagonists. Two specific compounds are 2-2-(3-bromo-2-pyridylmethylthio) ethylamino!-5-(2-hydroxy-4-pyridylmethyl)-4-pyrimidone and 2-4-(3-methoxy-2-pyridyl)butylamino!-5-(2-hydroxy-4-pyridylmethyl)-4-pyrimido ne.

Pyrimidine compounds

The compounds are substituted pyrimidine compounds which are histamine H2 -antagonists. A specific compound of the present invention is 2-[2-(5-dimethylaminomethyl)-2-furylmethylthio)ethylamino]-5-(3-pyridylmethyl)-4-pyrimidone.